Paula Voorheis, Julia Victoria Wong, Natasa Lazarevic, Bisma Imtiaz, Aunima Bhuiya, Carolyn Steele Gray
{"title":"Using Journey Mapping and Service Blueprinting to Design Digital Health Behavior Change Innovations: A Scoping Review.","authors":"Paula Voorheis, Julia Victoria Wong, Natasa Lazarevic, Bisma Imtiaz, Aunima Bhuiya, Carolyn Steele Gray","doi":"10.1177/19322968251334396","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Solutions to support disease self-management and health-related behavior changes require a deep understanding of patient experiences, needs, and challenges across the care journey. Journey mapping (JM) and service blueprinting (SB) are valuable tools for visualizing user experiences and system processes over time. This scoping review explores how JM/SBs have been applied to design digitally enabled interventions targeting health-related behaviors among patients and the public.</p><p><strong>Methods: </strong>The JBI reviewer manual was used to guide the review. Studies were sourced from Embase, Psych Info, PubMed, Medline, Web of Science, and Scopus. Inclusion criteria required studies to describe how JM/SBs informed the design of a digitally enabled health innovation that aimed to impact health or health care-related behaviors of patients or the public. A two-level screening process and iterative data extraction were applied.</p><p><strong>Results: </strong>A total of 28 studies met the inclusion criteria, with a majority published between 2019 and 2024. The JM/SBs rarely used behavioral science theory and were structured, organized, and presented in diverse ways. Most studies designed their digital health behavior change innovations by using JM/SB to identify relevant innovation touchpoints across the patient journey. Patients frequently participated in the digital health behavior change innovation design process, with JM/SBs often serving as sensemaking tools. Innovations tended to address multifaceted health service problems through multimodal, digitally enabled solutions.</p><p><strong>Conclusions: </strong>JM/SBs are emerging as versatile tools to help digital health innovations to conduct user research, engage diverse partners, identify complex problems, and ideate creative solutions. However, limited integration of behavioral science theory indicates an area for future exploration.</p>","PeriodicalId":15475,"journal":{"name":"Journal of Diabetes Science and Technology","volume":" ","pages":"19322968251334396"},"PeriodicalIF":3.7000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12061902/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/19322968251334396","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Solutions to support disease self-management and health-related behavior changes require a deep understanding of patient experiences, needs, and challenges across the care journey. Journey mapping (JM) and service blueprinting (SB) are valuable tools for visualizing user experiences and system processes over time. This scoping review explores how JM/SBs have been applied to design digitally enabled interventions targeting health-related behaviors among patients and the public.
Methods: The JBI reviewer manual was used to guide the review. Studies were sourced from Embase, Psych Info, PubMed, Medline, Web of Science, and Scopus. Inclusion criteria required studies to describe how JM/SBs informed the design of a digitally enabled health innovation that aimed to impact health or health care-related behaviors of patients or the public. A two-level screening process and iterative data extraction were applied.
Results: A total of 28 studies met the inclusion criteria, with a majority published between 2019 and 2024. The JM/SBs rarely used behavioral science theory and were structured, organized, and presented in diverse ways. Most studies designed their digital health behavior change innovations by using JM/SB to identify relevant innovation touchpoints across the patient journey. Patients frequently participated in the digital health behavior change innovation design process, with JM/SBs often serving as sensemaking tools. Innovations tended to address multifaceted health service problems through multimodal, digitally enabled solutions.
Conclusions: JM/SBs are emerging as versatile tools to help digital health innovations to conduct user research, engage diverse partners, identify complex problems, and ideate creative solutions. However, limited integration of behavioral science theory indicates an area for future exploration.
简介:支持疾病自我管理和健康相关行为改变的解决方案需要深入了解患者在整个护理过程中的经历、需求和挑战。旅程映射(JM)和服务蓝图(SB)是可视化用户体验和系统流程的宝贵工具。本综述探讨了JM/SBs如何应用于设计针对患者和公众健康相关行为的数字化干预措施。方法:采用JBI审稿人手册指导评价。研究来源于Embase, Psych Info, PubMed, Medline, Web of Science和Scopus。纳入标准要求研究描述JM/SBs如何为旨在影响患者或公众的健康或卫生保健相关行为的数字化卫生创新的设计提供信息。采用两级筛选和迭代数据提取。结果:共有28项研究符合纳入标准,大多数发表于2019年至2024年之间。JM/SBs很少使用行为科学理论,并且以多种方式结构化,有组织和呈现。大多数研究通过使用JM/SB来确定患者旅程中的相关创新接触点来设计其数字健康行为改变创新。患者经常参与数字健康行为改变创新设计过程,JM/SBs通常作为意义生成工具。创新倾向于通过多模式、数字化解决方案解决多方面的保健服务问题。结论:JM/SBs正在成为帮助数字卫生创新开展用户研究、吸引不同合作伙伴、识别复杂问题和构思创造性解决方案的多功能工具。然而,行为科学理论的有限整合表明了未来探索的领域。
期刊介绍:
The Journal of Diabetes Science and Technology (JDST) is a bi-monthly, peer-reviewed scientific journal published by the Diabetes Technology Society. JDST covers scientific and clinical aspects of diabetes technology including glucose monitoring, insulin and metabolic peptide delivery, the artificial pancreas, digital health, precision medicine, social media, cybersecurity, software for modeling, physiologic monitoring, technology for managing obesity, and diagnostic tests of glycation. The journal also covers the development and use of mobile applications and wireless communication, as well as bioengineered tools such as MEMS, new biomaterials, and nanotechnology to develop new sensors. Articles in JDST cover both basic research and clinical applications of technologies being developed to help people with diabetes.